Biotechnology · Health Care
Adaptive Biotech: Risk & public record
Adaptive Biotech: 235 research papers in five years.
Data updated Nov 20, 2026 · Back to the company report
What the registers and the postings say about this employer.
Legal entity active
Adaptive Biotechnologies Corp
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Public record
Adaptive Biotech: 235 research papers in five years.
Research outputpapers its people wrote, per OpenAlex
235papers in five years
41kcitations
T-cell and B-cell Immunology
Immunology and Microbiology
282 papers
Lymphoma Diagnosis and Treatment
Medicine
175 papers
Cancer Immunotherapy and Biomarkers
Medicine
169 papers
Immunotherapy and Immune Responses
Immunology and Microbiology
127 papers
Chronic Lymphocytic Leukemia Research
Medicine
119 papers
Works most with: United States Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Memorial Sloan Kettering Cancer Center, University of Washington, Mayo Clinic
Patents
Published US applications
3
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.
